Find verified Tofacitinib citrate API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Tofacitinib citrate for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Tofacitinib citrate API.
Alternate Names: Xeljanz, Tasocitinib monocitrate
CAS No: 540737-29-9
PubChem CID: 10174505
Mol Formula: C22H28N6O8
Mol Weight: 504.5 g/mol
IUPAC Name: 2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
API Description: Tofacitinib citrate is a citrate salt obtained by combining equimolar amounts of tofacitinib and citric acid. Used to treat moderately to severely active Rheumatoid Arthritis. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor and an antirheumatic drug. It contains a tofacitinib.TOFACITINIB CITRATE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for psoriatic arthritis and rheumatoid arthritis and has 4 investigational indications. This drug has a black box warning from the FDA.
